---
figid: PMC9312025__antioxidants-11-01297-g003
pmcid: PMC9312025
image_filename: antioxidants-11-01297-g003.jpg
figure_link: /pmc/articles/PMC9312025/figure/antioxidants-11-01297-f003/
number: Figure 3
figure_title: ''
caption: Illustration of the pentose phosphate pathway (PPP). Allopurinol-mediated
  inhibition of PPP reduces ribose-5-phosphate availability for purine synthesis,
  which likely contributes to the urate-lowering effect of the drug. Allopurinol,
  additionally, inhibits the oxidative branch of the PPP and may result in reduced
  availability NADPH.
article_title: Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress
  in CKD.
citation: Mingyao Sun, et al. Antioxidants (Basel). 2022 Jul;11(7):1297.
year: '2022'

doi: 10.3390/antiox11071297
journal_title: Antioxidants
journal_nlm_ta: Antioxidants (Basel)
publisher_name: MDPI

keywords:
- xanthine oxidase
- urate
- chronic kidney disease

---
